Publication date: Jul 09, 2025
Linear discriminant effect size analysis (LEfSe) was performed to obtain a linear discriminant analysis (LDA) score histogram .Statistical analysis was performed using R (version 4. 3.1). The alpha diversity was evaluated using the Shannon index and Observed species index, and compared between groups using the Wilcoxon rank-sum test. Normality test of the data was performed using the Shapiro-Wilk test, and non-parametric data are presented as the median and interquartile range. Significant differences in community composition were determined using permutational multivariate analysis of variance (PERMANOVA). Based on the distribution, either a Students t-test (for normally distributed data) or a Wilcoxon rank-sum test (for non-normally distributed data) was used to compare two groups. Samples were then vortexed (10 min intervals, 30 min at room temperature) and processed using a filter screen (70 m). To evaluate the risk of clinical comorbidities in children with TB, binary logistic regression analysis was performed, comparing TB patients with non-TB infectious disease controls.
| Concepts | Keywords |
|---|---|
| June | Based |
| Novogene | Clinical |
| Polyvinylpyrrolidone | Collected |
| Tuberculosis | Differences |
| Volcano | Lipid |
| Min | |
| Mtb | |
| Performed | |
| Plasma | |
| Reads | |
| Sequence | |
| Stool | |
| Tb | |
| Test | |
| Version |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | quality |
| disease | IDO | algorithm |
| disease | IDO | reagent |
| drug | DRUGBANK | Phosphate ion |
| drug | DRUGBANK | Edetic Acid |
| disease | IDO | history |
| disease | IDO | bacteria |
| drug | DRUGBANK | Cycloserine |
| disease | MESH | infectious diseases |
| pathway | REACTOME | Release |
| disease | IDO | assay |
| disease | MESH | abnormalities |
| disease | MESH | malnutrition |
| disease | MESH | weight loss |
| pathway | KEGG | Tuberculosis |
| disease | MESH | tuberculosis |
| disease | MESH | dysbiosis |
| drug | DRUGBANK | Flunarizine |
| drug | DRUGBANK | Aspartame |
| disease | IDO | process |
| pathway | REACTOME | Infectious disease |
| disease | IDO | infectious disease |